SCHEMBL30106360

SCHEMBL30106360

Cn1ccnc1C1(CNC(=O)c2c(Cl)cccc2-c2ccc(C(F)(F)F)cc2)NC(=O)NC1=O

nearest known ligand 0.77

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADAMTS7 Q9UKP4 17/20 0.77
ADAMTS4 O75173 4/20 0.59
ADAM17 P78536 4/20 0.59
ADAMTS5 Q9UNA0 4/20 0.59
MMP1 P03956 3/20 0.59
MMP2 P08253 3/20 0.59
MMP3 P08254 3/20 0.59
MMP7 P09237 3/20 0.59
MMP9 P14780 3/20 0.59
MMP13 P45452 3/20 0.59
MMP14 P50281 3/20 0.59
ADAM10 O14672 1/20 0.46
MMP12 P39900 1/20 0.46
MMP15 P51511 1/20 0.46
ADAMTS12 P58397 1/20 0.46
ADAM8 P78325 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29979734 0.91 ADAMTS7 (0.78) ADAMTS7ADAMTS4ADAM17ADAMTS5MMP1
SCHEMBL29979823 0.91 ADAMTS7 (0.78) ADAMTS7ADAMTS4ADAM17ADAMTS5MMP1
SCHEMBL24927857 0.91 ADAMTS7 (0.78) ADAMTS7ADAMTS4ADAM17ADAMTS5MMP1
SCHEMBL29978888 0.90 ADAMTS7 (0.62) ADAMTS7ADAMTS4ADAM17ADAMTS5MMP1
SCHEMBL29979674 0.90 ADAMTS7 (0.63) ADAMTS7ADAMTS4ADAM17ADAMTS5MMP1
SCHEMBL23371359 0.87 ADAMTS7 (1.00) ADAMTS7ADAMTS4ADAM17ADAMTS5MMP1
SCHEMBL24927863 0.85 ADAMTS7 (0.81) ADAMTS7ADAMTS4ADAM17ADAMTS5MMP1
SCHEMBL29979815 0.85 ADAMTS7 (0.84) ADAMTS7ADAMTS4ADAM17ADAMTS5MMP2
SCHEMBL23371360 0.84 ADAMTS7 (0.79) ADAMTS7ADAMTS4ADAM17ADAMTS5MMP1
SCHEMBL30106299 0.82 ADAMTS7 (0.77) ADAMTS7ADAMTS4ADAM17ADAMTS5ADAM10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists BAYER AKTIENGESELLSCHAFT (DE) 2025-08-26 US disclosed
EP-4058448-B1 HYDANTOIN DERIVATIVES AS ADAMTS7 ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER AG (DE) 2024-05-29 EP disclosed
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists ADAMTS7, MMP7, ADAM17 ADAMTS7 1/4885ADAMTS4 6/4885ADAM17 3/4885
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAM17 ADAMTS7 1/4885ADAMTS4 6/4885ADAM17 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.